Literature DB >> 34758323

Chromatin-state barriers enforce an irreversible mammalian cell fate decision.

M Andrés Blanco1, David B Sykes2, Lei Gu3, Mengjun Wu4, Ricardo Petroni5, Rahul Karnik6, Mathias Wawer7, Joshua Rico5, Haitao Li5, William D Jacobus4, Ashwini Jambhekar4, Sihem Cheloufi8, Alexander Meissner9, Konrad Hochedlinger10, David T Scadden11, Yang Shi12.   

Abstract

Stem and progenitor cells have the capacity to balance self-renewal and differentiation. Hematopoietic myeloid progenitors replenish more than 25 billion terminally differentiated neutrophils every day under homeostatic conditions and can increase this output in response to stress or infection. At what point along the spectrum of maturation do progenitors lose capacity for self-renewal and become irreversibly committed to differentiation? Using a system of conditional myeloid development that can be toggled between self-renewal and differentiation, we interrogate determinants of this "point of no return" in differentiation commitment. Irreversible commitment is due primarily to loss of open regulatory site access and disruption of a positive feedback transcription factor activation loop. Restoration of the transcription factor feedback loop extends the window of cell plasticity and alters the point of no return. These findings demonstrate how the chromatin state enforces and perpetuates cell fate and identify potential avenues for manipulating cell identity.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Hoxa9; acute myeloid leukemia; cell fate; chromatin; development; differentiation; epigenetics; hematopoiesis; lineage commitment

Mesh:

Substances:

Year:  2021        PMID: 34758323     DOI: 10.1016/j.celrep.2021.109967

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  10 in total

Review 1.  Reading oscillatory instructions: How cells achieve time-dependent responses to oscillating transcription factors.

Authors:  Veena Venkatachalam; Ashwini Jambhekar; Galit Lahav
Journal:  Curr Opin Cell Biol       Date:  2022-06-09       Impact factor: 8.386

2.  Metabolism-Associated DNA Methylation Signature Stratifies Lower-Grade Glioma Patients and Predicts Response to Immunotherapy.

Authors:  Guozheng Yang; Dezhi Shan; Rongrong Zhao; Gang Li
Journal:  Front Cell Dev Biol       Date:  2022-06-15

3.  A Systematic Analysis Reveals the Prognostic and Immunological Role of Reptin/RUVBL2 in Human Tumors.

Authors:  Xiaoru Su; Gaoming Zheng; Zhifang Gui; Xiao Yang; Lahong Zhang; Feng Pan
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

4.  Crosstalk Between Four Types of RNA Modification Writers Characterizes the Tumor Immune Microenvironment Infiltration Patterns in Skin Cutaneous Melanoma.

Authors:  Shichao Zhang; Yu Xiong; Chaochao Zheng; Jinhua Long; Houming Zhou; Zhu Zeng; Yan Ouyang; Fuzhou Tang
Journal:  Front Cell Dev Biol       Date:  2022-01-26

5.  Generation and Analysis of Pyroptosis-Based and Immune-Based Signatures for Kidney Renal Clear Cell Carcinoma Patients, and Cell Experiment.

Authors:  Gaoteng Lin; Qingfu Feng; Fangfang Zhan; Fan Yang; Yuanjie Niu; Gang Li
Journal:  Front Genet       Date:  2022-02-24       Impact factor: 4.599

6.  Uncovering N4-Acetylcytidine-Related mRNA Modification Pattern and Landscape of Stemness and Immunity in Hepatocellular Carcinoma.

Authors:  Sicheng Liu; Yaguang Zhang; Lei Qiu; Su Zhang; Yang Meng; Canhua Huang; Zhixin Chen; Bo Zhang; Junhong Han
Journal:  Front Cell Dev Biol       Date:  2022-04-14

7.  Characterization of chromatin regulators in hepatocellular carcinoma to guide clinical therapy.

Authors:  Xiangen Jia; Guozhi Zhang
Journal:  Front Genet       Date:  2022-08-25       Impact factor: 4.772

8.  Molecular characterization, clinical relevance and immune feature of m7G regulator genes across 33 cancer types.

Authors:  Zhanzhan Li; Yanyan Li; Lin Shen; Liangfang Shen; Na Li
Journal:  Front Genet       Date:  2022-08-25       Impact factor: 4.772

9.  Role of 5-methylcytosine in determining the prognosis, tumor microenvironment, and applicability of precision medicine in patients with hepatocellular carcinoma.

Authors:  Mingyuan Luan; Min Zhao; Haiying Wang; Rongjian Xu; Jinzhen Cai
Journal:  Front Genet       Date:  2022-09-16       Impact factor: 4.772

10.  Long Non-coding RNAs Gabarapl2 and Chrnb2 Positively Regulate Inflammatory Signaling in a Mouse Model of Dry Eye.

Authors:  Yuhan Yang; Minjie Chen; Zimeng Zhai; Yiqin Dai; Hao Gu; Xujiao Zhou; Jiaxu Hong
Journal:  Front Med (Lausanne)       Date:  2021-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.